Stay updated on Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.

Latest updates to the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a platform-level update to the page rendering. The study details and patient-focused information remain unchanged.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe header now shows Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1, and the lapse-in-funding notice has been removed. The study information on the page remains unchanged.SummaryDifference0.4%

- Check97 days agoChange DetectedAdded a government funding notice about potential delays and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Talimogene in Pleural Effusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Talimogene in Pleural Effusion Clinical Trial page.